Skip to Content
You are currently on the new version of our website. Access the old version .

Immuno, Volume 3, Issue 2

2023 June - 8 articles

Cover Story: Breast cancer is the most commonly diagnosed cancer in women and is a leading cause of cancer death in women worldwide. Despite the available treatment options, such as surgery, chemotherapy, radiotherapy, endocrine therapy and molecular targeted therapy, breast cancer treatment remains a challenge. Existing immunotherapies, including monoclonal antibodies against breast cancer-specific antigens and the use of immune checkpoint inhibitors, revolutionized the treatment of breast cancer. In this literature review, we aim to summarize the recent advancements made in using immunotherapy for treating breast cancer patients. Finally, we consider the development of breast cancer vaccines that train the immune system to specifically recognize cancer cells and the future perspectives of immunotherapy for breast cancer. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (8)

  • Article
  • Open Access
3 Citations
6,018 Views
13 Pages

Immunotherapeutic Development of a Tri-Specific NK Cell Engager Recognizing BCMA

  • Felix Oh,
  • Martin Felices,
  • Behiye Kodal,
  • Jeffrey S. Miller and
  • Daniel A. Vallera

20 June 2023

Chemotherapy-refractive multiple myeloma (MM) is serious and life-threatening, and better treatments are urgently needed. BCMA is a prominent marker on the cell surface of MM cells, rendering it an accepted target for antibody therapy. Considering th...

(This article belongs to the Section Cancer Immunology and Immunotherapy)
  • Review
  • Open Access
6 Citations
4,268 Views
9 Pages

Inflammatory Profile of Th9 Cells and Their Protective Potential in Helminth Infections

  • Yvanna Louise Di Christine Oliveira,
  • Yrna Lorena Matos de Oliveira,
  • Tatyane Martins Cirilo,
  • Ricardo Toshio Fujiwara and ,
  • Lilian Lacerda Bueno and
  • Silvio Santana Dolabella
  • + 1 author+ 0 author

8 June 2023

In terms of the global burden of disease, helminthiasis is the most common infectious disease in the world. In response to the disease, the human host develops an immunological response that occurs predominantly through the action of T helper 2 (Th2)...

(This article belongs to the Section Immunopathology and Immunohistology)
  • Review
  • Open Access
3 Citations
5,363 Views
11 Pages

Exploring the Potential of Plant-Based CTB-INS Oral Vaccines in Treating Type 1 Diabetes

  • Jacques C. Mbongue,
  • Elaine Vanterpool and
  • William H. R. Langridge

1 June 2023

The 19th century saw the development of vaccines, which were biological preparations designed to enhance immunity against specific diseases. Edible vaccines function by stimulating both systemic and mucosal immune responses against foreign pathogens,...

(This article belongs to the Section Mucosal Immunology)
  • Review
  • Open Access
11 Citations
8,266 Views
22 Pages

30 May 2023

Breast cancer is the most commonly diagnosed cancer in women and is a leading cause of cancer death in women worldwide. Despite the available treatment options, such as surgery, chemotherapy, radiotherapy, endocrine therapy and molecular targeted the...

(This article belongs to the Section Cancer Immunology and Immunotherapy)
  • Review
  • Open Access
16 Citations
6,717 Views
13 Pages

29 April 2023

Inflammation is considered a natural reaction of the immune system that can be caused by several factors such as pathogens, chemical substances, and damaged cells. Since the classical era, therapeutic substances have been made from medicinal plants....

  • Review
  • Open Access
15 Citations
13,369 Views
22 Pages

Immunopathogenesis of Nipah Virus Infection and Associated Immune Responses

  • Brent Brown,
  • Tanya Gravier,
  • Ingo Fricke,
  • Suhaila A. Al-Sheboul and ,
  • Theodor-Nicolae Carp,
  • Chiuan Yee Leow,
  • Chinua Imarogbe and
  • Javad Arabpour
  • + 3 authors+ 0 author

27 April 2023

Pandemics in the last two centuries have been initiated by causal pathogens that include Severe Acute Coronavirus 2 (SARS-CoV-2) and Influenza (e.g., the H1N1 pandemic of 2009). The latter is considered to have initiated two prior pandemics in 1918 a...

  • Article
  • Open Access
8 Citations
5,142 Views
12 Pages

Anti-Inflammatory and Anti-Adipogenesis Effects of Alchemilla vulgaris L., Salvia officinalis L., and Vitis vinifera L. in THP-1-Derived Macrophages and 3T3-L1 Cell Line

  • Bayan Mansour,
  • Nora Shaheen,
  • Abdalsalam Kmail,
  • Nawal Haggag and ,
  • Salah Saad,
  • Omar Sadiq,
  • Ramez Zaid and
  • Bashar Saad
  • + 3 authors+ 0 author

14 April 2023

The production of pro-inflammatory and anti-inflammatory cytokines, as well as adipocyte differentiation and fat accumulation in the 3T3-L1 mouse embryo fibroblast cell line and the human monocytic cell line THP-1 were measured to determine the anti-...

  • Review
  • Open Access
4 Citations
7,602 Views
26 Pages

Mimicry of Tumour-Associated Carbohydrates: Is It a Promising Option for Cancer Treatment?

  • Valeria Inés Segatori,
  • Gretel Magalí Ferreira,
  • Selene Rojo,
  • Aylen Camila Nogueira and ,
  • Jeremías Omar Castillo,
  • Cynthia Antonella Gulino and
  • Mariano Rolando Gabri
  • + 2 authors+ 0 author

23 March 2023

Modulation of the immune system has been demonstrated as a powerful approach to treating cancer. Immunotherapies are generally classified as active or passive according to their ability to trigger the immune system. During the last decades, informati...

(This article belongs to the Section Cancer Immunology and Immunotherapy)
XFacebookLinkedIn
Immuno - ISSN 2673-5601